Biosceptre announces positive Phase I results for BIL-010t to treat Basal Cell CarcinomaBiosceptre2014-07-23T07:00:42+10:00July 23rd, 2014|Clinical|Read More
Biosceptre publishes preclinical data on nf-P2X7 in the Journal of Clinical and Cellular ImmunologyBiosceptre2014-07-18T09:00:52+10:00July 18th, 2014|Clinical, Corporate|Read More
Biosceptre secures Technology Strategy Board AwardBiosceptre2014-07-16T07:00:24+10:00July 16th, 2014|Corporate|Read More
Biosceptre closes AUD5m financing from existing investorsBiosceptre2014-07-09T00:00:48+10:00July 9th, 2014|Clinical, Financial|Read More
Biosceptre moves corporate headquarters to the UK from AustraliaBiosceptre2014-02-21T07:00:16+11:00February 21st, 2014|Corporate|Read More